Items where Author is "Elliott, S"
Up a level |
Elliott, S, Maezumi, SY, Robinson, M, Burn, M, Gosling, WD, Mickleburgh, HL, Walters, S and Beier, ZJM (2022) The legacy of 1300 years of land use in Jamaica. Journal of Island and Coastal Archaeology. ISSN 1556-4894
Elliott, S, Holdbrook, T and Brandt, SD (2020) Prodrugs of new psychoactive substances (NPS): a new challenge. Journal of Forensic Sciences, 65 (3). pp. 913-920. ISSN 0022-1198
Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, de Morais, J, Sola, S and Sedefov, R (2017) Technical report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA). Annex 1 to the Risk Assessment Report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3- carboxamide (CUMYL-4CN-BINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.
Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Gallegos, A and Sedefov, R (2017) Technical report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Annex 1 to the Risk Assessment Report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.
Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Annex 1 to the Risk Assessment Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2- carboxamide (tetrahydrofuranylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.
Brandt, SD, Elliott, S, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, Evans-Brown, M and Sedefov, R (2017) Furanylfentanyl. ANNEX 1. Technical report on N-phenyl-N- [1-(2-phenylethyl)piperidin-4-yl]furan- 2-carboxamide (furanylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.
Elliott, S and Morrell-Scott, NE (2017) Care of patients undergoing weaning from mechanical ventilation in critical care. Nursing Standard, 32 (13). pp. 41-51. ISSN 0029-6570
Brandt, SD and Elliott, S (2016) Technical report on 1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Elliott, S and Brandt, SD (2014) Technical report on 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe). Annex 2 to the “Risk Assessment Report of a new psychoactive substance: 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe)”. Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Elliott, S and Brandt, S (2014) Technical report on 5-(2-aminopropyl)indole. Annex 1 to the “5-(2-Aminopropyl)indole (5-IT): Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances”. Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.